These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38452634)

  • 1. Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue.
    Pandya D; Tomita S; Rhenals MP; Swierczek S; Reid K; Camacho-Vanegas O; Camacho C; Engelman K; Polukort S; RoseFigura J; Chuang L; Andikyan V; Cohen S; Fiedler P; Sieber S; Shih IM; Billaud JN; Sebra R; Reva B; Dottino P; Martignetti JA
    Gynecol Oncol; 2024 Jun; 185():194-201. PubMed ID: 38452634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.
    Reid K; Camacho-Vanegas O; Pandya D; Camacho SC; Qiao RF; Kalir T; Padron-Rhenals MM; Beddoe AM; Dottino P; Martignetti JA
    Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37848227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
    Nair N; Camacho-Vanegas O; Rykunov D; Dashkoff M; Camacho SC; Schumacher CA; Irish JC; Harkins TT; Freeman E; Garcia I; Pereira E; Kendall S; Belfer R; Kalir T; Sebra R; Reva B; Dottino P; Martignetti JA
    PLoS Med; 2016 Dec; 13(12):e1002206. PubMed ID: 28027320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic mutations in histologically normal endometrium: the new normal?
    Lac V; Nazeran TM; Tessier-Cloutier B; Aguirre-Hernandez R; Albert A; Lum A; Khattra J; Praetorius T; Mason M; Chiu D; Köbel M; Yong PJ; Gilks BC; Anglesio MS; Huntsman DG
    J Pathol; 2019 Oct; 249(2):173-181. PubMed ID: 31187483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors.
    Aguilar M; Zhang H; Zhang M; Cantarell B; Sahoo SS; Li HD; Cuevas IC; Lea J; Miller DS; Chen H; Zheng W; Gagan J; Lucas E; Castrillon DH
    J Pathol; 2021 May; 254(1):20-30. PubMed ID: 33506979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
    Miller EM; Patterson NE; Gressel GM; Karabakhtsian RG; Bejerano-Sagie M; Ravi N; Maslov A; Quispe-Tintaya W; Wang T; Lin J; Smith HO; Goldberg GL; Kuo DYS; Montagna C
    BMC Med Genomics; 2020 Nov; 13(1):179. PubMed ID: 33256706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
    Lupini L; Scutiero G; Iannone P; Martinello R; Bassi C; Ravaioli N; Soave I; Bonaccorsi G; Lanza G; Gafà R; Loizzi V; Negrini M; Greco P
    Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13137. PubMed ID: 31412428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic landscape of endometrial clear cell carcinomas.
    DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
    J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy.
    Martignetti JA; Pandya D; Nagarsheth N; Chen Y; Camacho O; Tomita S; Brodman M; Ascher-Walsh C; Kolev V; Cohen S; Harkins TT; Schadt EE; Reva B; Sebra R; Dottino P
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30301868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards less invasive molecular diagnostics for endometrial cancer: massively parallel sequencing of endometrial lavage specimens in women attending for an office hysteroscopy.
    Chao A; Wu KY; Lin CY; Lee YS; Huang HJ; Tang YH; Weng CH; Chao AS; Chang TC; Lai CH; Wu RC
    J Mol Med (Berl); 2022 Sep; 100(9):1331-1339. PubMed ID: 35953603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset.
    Hong JH; Cho HW; Ouh YT; Lee JK; Chun Y; Gim JA
    J Gynecol Oncol; 2022 May; 33(3):e29. PubMed ID: 35128859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutations in endometrial cancers: relation to PTEN gene defects.
    Janiec-Jankowska A; Konopka B; Goluda C; Najmoła U
    Int J Gynecol Cancer; 2010 Feb; 20(2):196-202. PubMed ID: 20169661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenomyosis pathogenesis: insights from next-generation sequencing.
    Bulun SE; Yildiz S; Adli M; Wei JJ
    Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings.
    Liew PL; Huang RL; Wu TI; Liao CC; Chen CW; Su PH; Wang HC; Weng YC; Lai HC
    Clin Epigenetics; 2019 Nov; 11(1):170. PubMed ID: 31779688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
    Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
    Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
    Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
    Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Tamura R; Mori Y; Yamawaki K; Adachi S; Takahashi T; Kase H; Tanaka K; Yamamoto T; Motoyama T; Inoue I; Enomoto T
    Cell Rep; 2018 Aug; 24(7):1777-1789. PubMed ID: 30110635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients.
    Bolivar AM; Luthra R; Mehrotra M; Chen W; Barkoh BA; Hu P; Zhang W; Broaddus RR
    Mod Pathol; 2019 Mar; 32(3):405-414. PubMed ID: 30315273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.
    Catasus L; Gallardo A; Cuatrecasas M; Prat J
    Mod Pathol; 2008 Feb; 21(2):131-9. PubMed ID: 18084252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium.
    Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Adachi S; Kase H; Motoyama T; Inoue I; Enomoto T
    Hum Reprod; 2019 Oct; 34(10):1899-1905. PubMed ID: 31621846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.